658 related articles for article (PubMed ID: 24399815)
61. Serum paraoxonase 1 activity and lipid peroxidation levels in patients with age-related macular degeneration.
Baskol G; Karakucuk S; Oner AO; Baskol M; Kocer D; Mirza E; Saraymen R; Ustdal M
Ophthalmologica; 2006; 220(1):12-6. PubMed ID: 16374043
[TBL] [Abstract][Full Text] [Related]
62. Inflammatory biomarkers and oxidative stress measurements in patients with systemic lupus erythematosus with or without metabolic syndrome.
Lozovoy MA; Simão AN; Hohmann MS; Simão TN; Barbosa DS; Morimoto HK; Reiche EM; Cecchini R; Dichi I
Lupus; 2011 Nov; 20(13):1356-64. PubMed ID: 21868433
[TBL] [Abstract][Full Text] [Related]
63. Malondialdehyde and sulfhydryl groups as biomarkers of oxidative stress in patients with systemic lupus erythematosus.
Pérez YG; Pérez LC; Netto Rde C; Lima DS; Lima ES
Rev Bras Reumatol; 2012 Aug; 52(4):658-60. PubMed ID: 22885431
[TBL] [Abstract][Full Text] [Related]
64. Oxidative stress in white coat hypertension; role of paraoxonase.
Uzun H; Karter Y; Aydin S; Curgunlu A; Simşek G; Yücel R; Vehiyd S; Ertürk N; Kutlu A; Benian A; Yaldiran A; Oztürk E; Erdine S
J Hum Hypertens; 2004 Jul; 18(7):523-8. PubMed ID: 14985779
[TBL] [Abstract][Full Text] [Related]
65. The relationship between paraoxonase1-192 polymorphism and activity with coronary artery disease.
Mohamed RH; Mohamed RH; Karam RA; Abd El-Aziz TA
Clin Biochem; 2010 Apr; 43(6):553-8. PubMed ID: 20026099
[TBL] [Abstract][Full Text] [Related]
66. Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus.
Juretić D; Motejlkova A; Kunović B; Rekić B; Flegar-Mestrić Z; Vujić L; Mesić R; Lukac-Bajalo J; Simeon-Rudolf V
Acta Pharm; 2006 Mar; 56(1):59-68. PubMed ID: 16613735
[TBL] [Abstract][Full Text] [Related]
67. Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus.
Mansour RB; Lassoued S; Gargouri B; El Gaïd A; Attia H; Fakhfakh F
Scand J Rheumatol; 2008; 37(2):103-8. PubMed ID: 18415766
[TBL] [Abstract][Full Text] [Related]
68. Oxidative stress in systemic lupus erythematosus: relationship to Th1 cytokine and disease activity.
Shah D; Kiran R; Wanchu A; Bhatnagar A
Immunol Lett; 2010 Mar; 129(1):7-12. PubMed ID: 20105444
[TBL] [Abstract][Full Text] [Related]
69. Main determinants of PON1 activity in hemodialysis patients.
Ribeiro S; do Sameiro Faria M; Mascarenhas-Melo F; Freitas I; Mendonça MI; Nascimento H; Rocha-Pereira P; Miranda V; Mendonça D; Quintanilha A; Belo L; Costa E; Reis F; Santos-Silva A
Am J Nephrol; 2012; 36(4):317-23. PubMed ID: 23007074
[TBL] [Abstract][Full Text] [Related]
70. Association of serum amyloid A and oxidative stress with paraoxonase 1 in sarcoidosis patients.
Ivanišević J; Kotur-Stevuljević J; Stefanović A; Spasić S; Vučinić Mihailović V; Videnović Ivanov J; Jelić-Ivanović Z
Eur J Clin Invest; 2016 May; 46(5):418-24. PubMed ID: 26919159
[TBL] [Abstract][Full Text] [Related]
71. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism.
Torun AN; Kulaksizoglu S; Kulaksizoglu M; Pamuk BO; Isbilen E; Tutuncu NB
Clin Endocrinol (Oxf); 2009 Mar; 70(3):469-74. PubMed ID: 18727709
[TBL] [Abstract][Full Text] [Related]
72. Interaction of paraoxonase-192 polymorphism with low HDL-cholesterol in coronary artery disease risk.
Mendonça MI; Dos Reis RP; Freitas AI; Pereira A; Sousa AC; Freitas S; Ornelas I; Freitas C; Brehm A; Araújo JJ
Rev Port Cardiol; 2010 Apr; 29(4):571-80. PubMed ID: 20734577
[TBL] [Abstract][Full Text] [Related]
73. Assessment of paraoxonase activity and lipid peroxidation levels in diabetic and senile subjects suffering from cataract.
Hashim Z; Zarina S
Clin Biochem; 2007 Jun; 40(9-10):705-9. PubMed ID: 17466963
[TBL] [Abstract][Full Text] [Related]
74. Evaluation of endothelial dysfunction, lipid metabolism in women with polycystic ovary syndrome: relationship of paraoxonase 1 activity, malondialdehyde levels, low-density lipoprotein subfractions, and endothelial dysfunction.
Bayram F; Kocer D; Ozsan M; Muhtaroglu S
Gynecol Endocrinol; 2012 Jul; 28(7):497-501. PubMed ID: 22703625
[TBL] [Abstract][Full Text] [Related]
75. PON1 M/L55 mutation protects high-risk patients against coronary artery disease.
Oliveira SA; Mansur AP; Ribeiro CC; Ramires JA; Annichino-Bizzacchi JM
Int J Cardiol; 2004 Mar; 94(1):73-7. PubMed ID: 14996478
[TBL] [Abstract][Full Text] [Related]
76. Significance of Lipid-Derived Reactive Aldehyde-Specific Immune Complexes in Systemic Lupus Erythematosus.
Wang G; Pierangeli SS; Willis R; Gonzalez EB; Petri M; Khan MF
PLoS One; 2016; 11(10):e0164739. PubMed ID: 27749917
[TBL] [Abstract][Full Text] [Related]
77. Serum paraoxonase-1 gene polymorphism and enzyme activity in patients with urolithiasis.
Atar A; Gedikbasi A; Sonmezay E; Kiraz ZK; Abbasoglu S; Tasci AI; Tugcu V
Ren Fail; 2016; 38(3):378-82. PubMed ID: 26795139
[TBL] [Abstract][Full Text] [Related]
78. The rs662 polymorphism of paraoxonase 1 affects the difference in the inhibition of butyrylcholinesterase activity by organophosphorus pesticides in human blood.
Nam DC; Ha YM; Park MK; Cho SK
Int J Clin Pharmacol Ther; 2016 Aug; 54(8):622-7. PubMed ID: 27087156
[TBL] [Abstract][Full Text] [Related]
79. Serum paraoxonase level and paraoxonase polymorphism in patients with acromegaly.
Arpaci D; Karakas Celik S; Can M; Ermiş E; Kuzu F; Kokturk F; Hamamcioglu AC; Dursun A; Bayraktaroglu T
Redox Rep; 2016 Nov; 21(6):281-6. PubMed ID: 26863932
[TBL] [Abstract][Full Text] [Related]
80. Alteration of HDL functionality and PON1 activities in acute coronary syndrome patients.
Bounafaa A; Berrougui H; Ikhlef S; Essamadi A; Nasser B; Bennis A; Yamoul N; Ghalim N; Khalil A
Clin Biochem; 2014 Dec; 47(18):318-25. PubMed ID: 25218815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]